146 related articles for article (PubMed ID: 3307874)
41. Quinone oxidoreductase message levels are differentially regulated in parasitic and non-parasitic plants exposed to allelopathic quinones.
Matvienko M; Wojtowicz A; Wrobel R; Jamison D; Goldwasser Y; Yoder JI
Plant J; 2001 Feb; 25(4):375-87. PubMed ID: 11260494
[TBL] [Abstract][Full Text] [Related]
42. omicron-Quinone formation in the biochemical oxidation of the antitumor drug N2-methyl-9-hydroxyellipticinium acetate.
Bernadou J; Meunier G; Paoletti C; Meunier B
J Med Chem; 1983 Apr; 26(4):574-9. PubMed ID: 6834391
[TBL] [Abstract][Full Text] [Related]
43. [Criteria selection for the preliminary evaluation of the efficacy of antihypoxic agents].
Lunets EF; Tatarinov BA; Petrovskiĭ CG
Biofizika; 1976 Nov; 21(6):1054-8. PubMed ID: 1009197
[TBL] [Abstract][Full Text] [Related]
44. [Clinical experiences with ethyleneimino-quinone (E 39) in chemotherapy of various neoplasms].
DI PIETRO S
Riforma Med; 1957 Jun; 71(22):608-14. PubMed ID: 13454502
[No Abstract] [Full Text] [Related]
45. Pro- and antioxidant functions of quinones and quinone reductases in mammalian cells.
Cadenas E; Hochstein P; Ernster L
Adv Enzymol Relat Areas Mol Biol; 1992; 65():97-146. PubMed ID: 1570770
[No Abstract] [Full Text] [Related]
46. [Failure of attempted treatment of multiregional lymphosarcomatosis with the new antitumoral quinone E 39].
MOULINIER J
J Med Bord; 1957 Jul; 134(7):953-6. PubMed ID: 13449493
[No Abstract] [Full Text] [Related]
47. Twenty-first Paterson symposium: bioactivation of quinone anti-tumor agents.
Br J Cancer; 1987 Mar; 55(3):327-30. PubMed ID: 3105571
[No Abstract] [Full Text] [Related]
48. [Critical evaluation of certain results obtained with E-39].
FARELLO G
Riforma Med; 1957 Jun; 71(22):630-5. PubMed ID: 13454507
[No Abstract] [Full Text] [Related]
49. [Use of Bayer E 39 in otolaryngology; clinical and histological study].
BAUER E
Krebsarzt; 1957 Jun; 12(3):129-50. PubMed ID: 13450291
[No Abstract] [Full Text] [Related]
50. Metabolism and reactions of quinoid anticancer agents.
Powis G
Pharmacol Ther; 1987; 35(1-2):57-162. PubMed ID: 3321102
[No Abstract] [Full Text] [Related]
51. [Prolonged oral medication of Bayer E39 (cytostatic)].
HESSE F; KAMPEN G
Krebsarzt; 1957 Jun; 12(3):150-6. PubMed ID: 13450292
[No Abstract] [Full Text] [Related]
52. [E 39, a new antitumoral substance of the ethyleneimine-qulnone group; properties and clinical indications].
PESTEL M
Presse Med (1893); 1956 Sep; 64(64):1474-5. PubMed ID: 13379258
[No Abstract] [Full Text] [Related]
53. Photooxidation of chlorins by quinones studied by nuclear magnetic resonance techniques.
Lamola AA; Manion ML; Roth HD; Tollin G
Proc Natl Acad Sci U S A; 1975 Sep; 72(9):3265-9. PubMed ID: 16592269
[TBL] [Abstract][Full Text] [Related]
54. [Attempted treatment of advanced cancer with a derivative of the ethylene-imine-quinone group (E 39 or 6870 RP)].
JANBON M; BERTRAND L; BERTRAND A; FLANDRE O
Montp Med; 1958 Jun; 53(6):863-4. PubMed ID: 13589947
[No Abstract] [Full Text] [Related]
55. Biotechnology and biosynthesis of quinones.
Van den Berg AJ
Pharm Weekbl Sci; 1991 Apr; 13(2):74-7. PubMed ID: 1870946
[TBL] [Abstract][Full Text] [Related]
56. The role of the quinone in oxidative phosphorylation in Mycobacterium phlei. Evidence against carbon-oxygen bond cleavage.
Snyder CD; Rapoport H
J Am Chem Soc; 1967 Mar; 89(5):1269-71. PubMed ID: 6041351
[No Abstract] [Full Text] [Related]
57. Chemotherapy of cancer by ethylenimino quinones; its foundations and problems.
DOMAGK G
Ann N Y Acad Sci; 1958 Apr; 68(3):1197-204. PubMed ID: 13627772
[No Abstract] [Full Text] [Related]
58. Immunomodulation by quinones. A model for the use of quinones in the treatment of inflammation.
'T Hart LA
Pharm Weekbl Sci; 1991 Jun; 13(3):127-9. PubMed ID: 1923702
[TBL] [Abstract][Full Text] [Related]
59. Visible-light unmasking of heterocyclic quinone methide radicals from alkoxyamines.
Kielty P; Farràs P; McArdle P; Smith DA; Aldabbagh F
Chem Commun (Camb); 2019 Dec; 55(97):14665-14668. PubMed ID: 31746856
[TBL] [Abstract][Full Text] [Related]
60. [CELL CULTURE STUDIES ON MELANOMA THERAPY].
SOELTZ-SZOETS J
Wien Med Wochenschr; 1963 Oct; 113():802-4. PubMed ID: 14094995
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
